Home > News > Dabur Pharma eyes China & Japan entry
August 2nd, 2007
Dabur Pharma eyes China & Japan entry
Abstract:
Domestic anti-cancer drug major Dabur Pharma is finalising plans to enter Japan and China. The company has started the groundwork of filing drug applications and is scouting for potential pharma acquisitions in both the countries.
Dabur Pharma also plans to expand the range of products developed on its nanotechnology drug delivery system, christened ‘Nanoxel'. At the moment, it sells the popular anti-cancer drug ‘Paclitaxel' on this platform. "We also want to export this portfolio of drugs in US, Europe and South-east Asian markets," said Mr Vij.
Source:
economictimes.indiatimes.com
Bookmark:
Nanomedicine
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Announcements
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013
Acquisitions/Mergers/Splits
Mincom Capital Inc. and Group Nanoxplore Inc. Sign Letter of Intent for a Qualifying Transaction April 10th, 2013
SUNY NanoCollege and Children's Museum of Science and Technology Announce Agreement for CMOST to Become Part of CNSE: Under CNSE’s leadership, museum will be transformed into a flagship science center to educate in the emerging 21st century science and engineering disciplines February 6th, 2013
Lumineq plant now world’s largest ALD-enabled product factory February 4th, 2013
Nanostart AG reorganizes Asia business: Focus on Asian markets - Launch of 100-percent subsidiary February 4th, 2013